subject: CHEBI:28939

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Nasopharyngeal squamous cell carcinoma stage II

tested_intervention: unsure


subject: CHEBI:28939

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:28939

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:28939

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:28939

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:28939

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:28939

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:28939

object_name: stage IVC lymphoepithelioma of the oropharynx


subject: CHEBI:28939

object_name: Oropharyngeal lymphoepithelioma stage III


subject: CHEBI:28939

object_name: stage IVB lymphoepithelioma of the oropharynx


subject: CHEBI:28939

object_name: Nasopharyngeal squamous cell carcinoma stage I


subject: CHEBI:28939

object_name: Oropharyngeal lymphoepithelioma stage II


subject: CHEBI:28939

object_name: Oropharyngeal lymphoepithelioma stage I


subject: CHEBI:28939

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:28939

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:28939

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:28939

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:28939

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:28939

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:28939

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:28939

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:28939

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:28939

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: Laryngeal verrucous carcinoma stage III


subject: CHEBI:28939

object_name: Laryngeal squamous cell carcinoma stage II


subject: CHEBI:28939

object_name: Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: CHEBI:28939

object_name: Laryngeal verrucous carcinoma stage II


subject: CHEBI:28939

object_name: Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:28939

object_name: Nasopharyngeal lymphoepithelioma stage II


subject: CHEBI:28939

object_name: Laryngeal squamous cell carcinoma stage I


subject: CHEBI:28939

object_name: Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: Stage IVA Basal Cell Lip Carcinoma


subject: CHEBI:28939

object_name: Laryngeal verrucous carcinoma stage I


subject: CHEBI:28939

object_name: Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:28939

object_name: Nasopharyngeal lymphoepithelioma stage I


subject: CHEBI:28939

object_name: Stage III Lip Basal Cell Carcinoma


subject: CHEBI:28939

object_name: Stage IVB Basal Cell Lip Carcinoma


subject: CHEBI:28939

object_name: Stage IVC Basal Cell Lip Carcinoma


subject: CHEBI:28939

object_name: Stage II Lip Basal Cell Carcinoma


subject: CHEBI:28939

object_name: Stage I Lip Basal Cell Carcinoma


subject: CHEBI:17561

subject_name: Cysteine

object_name: mucositis


subject: CHEBI:17561

object_name: tongue cancer


subject: CHEBI:17561

object_name: tongue carcinoma


subject: CHEBI:17561

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:17561

object_name: Salivary gland cancer stage I


subject: CHEBI:17561

object_name: Stage I Major Salivary Gland Cancer AJCC v7


subject: CHEBI:17561

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:17561

object_name: stage IVA salivary gland cancer


subject: CHEBI:17561

object_name: Stage II Major Salivary Gland Cancer AJCC v7


subject: CHEBI:17561

object_name: Salivary gland cancer stage II


subject: CHEBI:17561

object_name: stage IVC salivary gland cancer


subject: CHEBI:17561

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:17561

object_name: Salivary gland cancer stage III


subject: CHEBI:17561

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: CHEBI:17561

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:17561

object_name: stage IVB salivary gland cancer


subject: CHEBI:17561

object_name: Oral Complication


subject: CHEBI:17561

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:17561

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:17561

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:17561

object_name: Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: stage IVA mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:17561

object_name: Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: stage IVA adenoid cystic carcinoma of the oral cavity


subject: CHEBI:17561

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:17561

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:17561

object_name: Mucoepidermoid carcinoma of the oral cavity stage I


subject: CHEBI:17561

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:17561

object_name: Mucoepidermoid carcinoma of the oral cavity stage II


subject: CHEBI:17561

object_name: Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: stage IVB mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:17561

object_name: Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: stage IVC mucoepidermoid carcinoma of the oral cavity


subject: CHEBI:17561

object_name: Mucoepidermoid carcinoma of the oral cavity stage III


subject: CHEBI:17561

object_name: Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: Stage III Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:17561

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:17561

object_name: Verrucous carcinoma of the oral cavity stage I


subject: CHEBI:17561

object_name: Verrucous carcinoma of the oral cavity stage II


subject: CHEBI:17561

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:17561

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:17561

object_name: Verrucous carcinoma of the oral cavity stage III


subject: CHEBI:17561

object_name: Adenoid cystic carcinoma of the oral cavity stage I


subject: CHEBI:17561

object_name: Adenoid cystic carcinoma of the oral cavity stage II


subject: CHEBI:17561

object_name: stage IVC adenoid cystic carcinoma of the oral cavity


subject: CHEBI:17561

object_name: Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: stage IVB adenoid cystic carcinoma of the oral cavity


subject: CHEBI:17561

object_name: Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: Adenoid cystic carcinoma of the oral cavity stage III


subject: CHEBI:17561

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:17561


subject: CHEBI:17561

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:17561

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:17561

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:17561

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:17561

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:17561

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:17561

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:17561

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:17561

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:17561

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:17561

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:17561

object_name: stage IVA lymphoepithelioma of the oropharynx


subject: CHEBI:17561

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: CHEBI:17561

object_name: Nasopharyngeal squamous cell carcinoma stage III


subject: CHEBI:17561

object_name: Nasopharyngeal squamous cell carcinoma stage II


subject: CHEBI:17561

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:17561

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:17561

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:17561

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:17561

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:17561

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:17561

object_name: stage IVC lymphoepithelioma of the oropharynx


subject: CHEBI:17561

object_name: Oropharyngeal lymphoepithelioma stage III


subject: CHEBI:17561

object_name: stage IVB lymphoepithelioma of the oropharynx


subject: CHEBI:17561

object_name: Nasopharyngeal squamous cell carcinoma stage I


subject: CHEBI:17561

object_name: Oropharyngeal lymphoepithelioma stage II


subject: CHEBI:17561

object_name: Oropharyngeal lymphoepithelioma stage I


subject: CHEBI:17561

object_name: Laryngeal squamous cell carcinoma stage III


subject: CHEBI:17561

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:17561

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:17561

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:17561

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:17561

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:17561

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:17561

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:17561

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:17561

object_name: Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: Laryngeal verrucous carcinoma stage III


subject: CHEBI:17561

object_name: Laryngeal squamous cell carcinoma stage II


subject: CHEBI:17561

object_name: Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: Nasopharyngeal lymphoepithelioma stage III


subject: CHEBI:17561

object_name: Laryngeal verrucous carcinoma stage II


subject: CHEBI:17561

object_name: Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:17561

object_name: Nasopharyngeal lymphoepithelioma stage II


subject: CHEBI:17561

object_name: Laryngeal squamous cell carcinoma stage I


subject: CHEBI:17561

object_name: Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: Stage IVA Basal Cell Lip Carcinoma


subject: CHEBI:17561

object_name: Laryngeal verrucous carcinoma stage I


subject: CHEBI:17561

object_name: Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7


subject: CHEBI:17561

object_name: Nasopharyngeal lymphoepithelioma stage I


subject: CHEBI:17561

object_name: Stage III Lip Basal Cell Carcinoma


subject: CHEBI:17561

object_name: Stage IVB Basal Cell Lip Carcinoma


subject: CHEBI:17561

object_name: Stage IVC Basal Cell Lip Carcinoma


subject: CHEBI:17561

object_name: Stage II Lip Basal Cell Carcinoma


subject: CHEBI:17561

object_name: Stage I Lip Basal Cell Carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Incidental Gallbladder Carcinoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: High Grade Squamous Intraepithelial Neoplasia


subject: PUBCHEM.COMPOUND:14907381

object_name: High-Grade Squamous Intraepithelial Lesions


subject: PUBCHEM.COMPOUND:14907381

object_name: human papilloma virus infection


subject: PUBCHEM.COMPOUND:14907381

object_name: HIV infection


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:36704

subject_name: Imiquimod


subject: CHEBI:36704

tested_intervention: yes


subject: CHEBI:36704

object_name: anus cancer


subject: CHEBI:36704

object_name: anal carcinoma


subject: CHEBI:36704


subject: CHEBI:36704


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Alopecia, CTCAE


subject: CHEBI:95341

object_name: Pathological Conditions, Anatomical


subject: CHEBI:95341

object_name: hair disease


subject: CHEBI:95341

object_name: hypotrichosis


subject: CHEBI:95341

object_name: skin disorder


subject: UMLS:C1517365

subject_name: GM-CSF DNA

object_name: melanoma


subject: UNII:N8O7MY0VNS

subject_name: LACUTAMAB

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:N8O7MY0VNS

object_name: Recurrence


subject: UMLS:C4085975

subject_name: Lacutamab


subject: UMLS:C4085975


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: oral cavity squamous cell carcinoma


subject: UNII:52CMI0WC3Y

object_name: squamous cell carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UNII:6XG22YQM2Z


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: GTOPDB:9615

object_name: metastatic colorectal cancer


subject: UMLS:C3658787


subject: UNII:S098K6HGD9


subject: UMLS:C4684904

subject_name: Aldoxorubicin Hydrochloride


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C4722367


subject: DRUGBANK:DB17528


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: UMLS:C4758796


subject: UNII:FIJ3OLQ3N8


subject: UMLS:C2826130

subject_name: Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207


subject: UMLS:C4722124


subject: UNII:B0L24T8TB7


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C5777124

subject_name: CD-16 NK-92 cells


subject: UMLS:C4552849

subject_name: haNK


subject: CHEBI:131164

subject_name: Osugacestat

object_name: Pre T-ALL


subject: CHEBI:131164

object_name: T-lymphoblastic lymphoma


subject: UNII:K911R84KEW

subject_name: Margetuximab

object_name: Stomach cancer


subject: UNII:K911R84KEW

object_name: gastric cancer


subject: UMLS:C2984521

subject_name: MGAH22 antibody


subject: UMLS:C2984521


subject: UMLS:C5204716


subject: UMLS:C5204716

object_name: Post-polycythemia vera myelofibrosis


subject: UMLS:C5204716

object_name: myelofibrosis


subject: UNII:2CMX9GYR6H

object_name: Urinary Bladder, Underactive


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: aneurysm


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:169833

subject_name: Deacetyldiltiazem

object_name: Reperfusion Injury


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:16586

subject_name: Aminocaproic acid

object_name: Intraoperative Hemorrhage


subject: DRUGBANK:DB18189

subject_name: AGuIX

object_name: glioblastoma


subject: DRUGBANK:DB18189

object_name: Childhood Glioblastoma


subject: DRUGBANK:DB18189

object_name: adult glioblastoma


subject: CHEBI:76400

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:76400

object_name: acute myeloid leukemia


subject: CHEBI:76400

object_name: acute promyelocytic leukemia


subject: CHEMBL.COMPOUND:CHEMBL4525123

subject_name: HMA


subject: CHEMBL.COMPOUND:CHEMBL4525123


subject: CHEMBL.COMPOUND:CHEMBL4525123


subject: UMLS:C3827077


subject: UMLS:C3827077


subject: UMLS:C3827077


subject: UMLS:C3274572

subject_name: Honey-containing Mouthwash

object_name: Xerostomia


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: Complex atypical endometrial hyperplasia


subject: CHEBI:6715

object_name: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma


subject: CHEBI:6715

object_name: FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: alopecia areata


subject: CHEBI:3160

object_name: alopecia


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: Memory observations


subject: UMLS:C5555917

subject_name: Pamvatamig

object_name: non-small cell lung carcinoma


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: asthma


subject: CHEBI:25681

object_name: Wheezing


subject: CHEBI:25681

object_name: Wheezing, CTCAE


subject: CHEBI:25681

object_name: Cognition disorders in children


subject: CHEBI:25681

object_name: respiratory tract infectious disorder


subject: CHEBI:25681

object_name: digestive system infectious disorder


subject: CHEBI:25681

object_name: Diagnosis, Psychiatric


subject: CHEBI:25681

object_name: atopic eczema


subject: CHEBI:25681

object_name: dermatitis


subject: CHEBI:25681

object_name: Eczema, CTCAE


subject: CHEBI:25681

object_name: croup


subject: CHEBI:25681

object_name: Subglottic laryngitis


subject: CHEBI:140621

subject_name: Cisatracurium

object_name: Postoperative Residual Curarization


subject: CHEBI:8884

subject_name: Rocuronium


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: benign neoplasm


subject: UMLS:C4086546

object_name: Benign obstetric neoplasm


subject: UMLS:C4086546

object_name: respiratory system benign neoplasm


subject: UMLS:C1515687

subject_name: PANVAC-F

object_name: colorectal cancer


subject: UMLS:C1515687

object_name: colorectal carcinoma


subject: UMLS:C1515687

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1515687

object_name: ovarian cancer


subject: UMLS:C1515687

object_name: ovarian neoplasm


subject: UMLS:C1515687

object_name: ovarian carcinoma


subject: UMLS:C1515687

object_name: Childhood Breast Carcinoma


subject: UMLS:C1515687

object_name: breast carcinoma


subject: UMLS:C1515687

object_name: breast cancer


subject: UMLS:C1515687

object_name: esophageal adenocarcinoma


subject: UMLS:C1515687

object_name: lung adenocarcinoma


subject: UMLS:C1515687

object_name: cervical adenocarcinoma


subject: UMLS:C1515687

object_name: adenocarcinoma


subject: UMLS:C1515687

object_name: bile duct adenocarcinoma


subject: UMLS:C1515687

object_name: gastric adenocarcinoma


subject: UMLS:C1515694

subject_name: PANVAC-V


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UMLS:C1515694


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: GTOPDB:4942

subject_name: GM-CSF


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C5417866

subject_name: EphA2-targeting Bicycle Toxin Conjugate BT5528


subject: UMLS:C5417866


subject: UMLS:C5417866


subject: UMLS:C5417866

object_name: Neck Carcinoma


subject: UMLS:C5417866

object_name: head and neck neoplasm


subject: UMLS:C5417866

object_name: head and neck cancer


subject: UMLS:C5417866

object_name: triple-negative breast carcinoma


subject: UMLS:C5417866

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5417866

object_name: non-small cell lung carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: bacterial infectious disease


subject: UMLS:C2987384

subject_name: BMN 673

object_name: ovarian cancer


subject: UMLS:C2987384

object_name: ovarian neoplasm


subject: UMLS:C2987384

object_name: ovarian carcinoma


subject: CHEBI:8772

subject_name: Raloxifene

object_name: pelvic pain on the left


subject: CHEBI:8772

object_name: pelvic pain occurs with urination


subject: CHEBI:8772

object_name: pelvic pain occurs with bowel movement


subject: CHEBI:8772

object_name: pelvic pain decreasing in severity


subject: CHEBI:8772

object_name: Pelvic pain female


subject: CHEBI:8772

object_name: pelvic pain increasing in severity


subject: CHEBI:8772

object_name: male pelvic pain


subject: CHEBI:8772

object_name: pelvic pain to the rear


subject: CHEBI:8772

object_name: pelvic pain on the right


subject: CHEBI:8772

object_name: pelvic pain decreasing in frequency


subject: CHEBI:8772

object_name: Pelvic pain


subject: CHEBI:8772

object_name: Pelvic Pain, CTCAE 5.0


subject: CHEBI:8772

object_name: pelvic pain causes awakening at night


subject: CHEBI:8772

object_name: pelvic pain increasing in frequency


subject: CHEBI:8772

object_name: pelvic pain occurs with intercourse


subject: CHEBI:8772

object_name: pelvic pain in front


subject: CHEBI:8772

object_name: endometriosis


subject: CHEBI:25805

subject_name: oxygen atom

object_name: respiratory system disorder


subject: CHEBI:25805

object_name: nervous system disorder


subject: CHEBI:25805

object_name: cardiovascular disorder


subject: CHEBI:25805

object_name: immune system disorder


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:15379


subject: CHEBI:15379


subject: PUBCHEM.COMPOUND:46208366

subject_name: LINAPRAZAN GLURATE

object_name: Heartburn


subject: UNII:3VG4D399DT


subject: CHEBI:90942

subject_name: Ixazomib

object_name: Kaposi Sarcoma


subject: CHEBI:90942

object_name: Skin and subcutaneous tissue disorders


subject: CHEBI:90942

object_name: skin neoplasm


subject: CHEBI:90942

object_name: Neoplasm of uncertain or unknown behavior of skin


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: Childhood Breast Carcinoma


subject: GTOPDB:12966

object_name: breast carcinoma


subject: GTOPDB:12966

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210


subject: UMLS:C4727210


subject: MESH:C483503

subject_name: neurexan

object_name: acute stress disorder


subject: CHEBI:5948

subject_name: Iodine aqueous

object_name: Graves disease


subject: CHEBI:63631

subject_name: Topiramate

object_name: traumatic encephalopathy


subject: UMLS:C1120338

subject_name: casein phosphopeptide-amorphous calcium phosphate nanocomplex

object_name: Orthodontic appliance complication


subject: UMLS:C2930770

object_name: Complicated urinary tract infection


subject: PUBCHEM.COMPOUND:49863420

subject_name: ceftolozane


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: aortic aneurysm


subject: UMLS:C1527137

object_name: Aortic aneurysm without mention of rupture NOS


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: PUBCHEM.COMPOUND:3367

object_name: adult T-cell leukemia/lymphoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat

object_name: adult acute myeloid leukemia


subject: UMLS:C0599220

subject_name: Protein Subunits


subject: UMLS:C0599220

object_name: Vaccine-Preventable Diseases


subject: UMLS:C5565764

subject_name: Novavax vaccine


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: acute kidney failure


subject: CHEBI:28787

object_name: Acute Kidney Injury, CTCAE


subject: MESH:C000708971

subject_name: genexol-PM

object_name: liver carcinoma


subject: UMLS:C1831860

subject_name: Beneo Synergy 1

object_name: leukopenia


subject: UMLS:C1831860

object_name: neutropenia


subject: UMLS:C1831860

object_name: cancer


subject: UMLS:C1831860

object_name: neoplasm


subject: UMLS:C1831860

object_name: Febrile Neutropenia


subject: UMLS:C1831860

object_name: Febrile Neutropenia, CTCAE


subject: UMLS:C1831860

object_name: Infection in an immunocompromised host


subject: UMLS:C4331926

subject_name: PROBIO-FIX INUM


subject: UMLS:C4331926


subject: UMLS:C4331926


subject: UMLS:C4331926


subject: UMLS:C4331926


subject: UMLS:C4331926


subject: UMLS:C4331926


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: pancreatic neuroendocrine tumor


subject: CHEBI:91397

object_name: Neuroendocrine tumor of pancreas


subject: CHEBI:91397

object_name: carcinoid tumor


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: cesarean section; complications


subject: UMLS:C1709066

object_name: Hodgkin Disease


subject: UMLS:C1709066

object_name: non-Hodgkin lymphoma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Bone fracture


subject: CHEBI:46195

object_name: Fracture, CTCAE


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UNII:Q830PW7520

subject_name: CODEINE


subject: UNII:Q830PW7520


subject: PUBCHEM.COMPOUND:2828


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:57871


subject: CHEBI:57871


subject: CHEBI:16714

subject_name: Codeine


subject: CHEBI:16714


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: UNII:28X28X9OKV

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C0042210

subject_name: Vaccines

object_name: tick-borne encephalitis


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: prostate neoplasm


subject: UNII:WKM56H3TLB

subject_name: Myrcludex B

object_name: Hepatitis D, Chronic


subject: CHEBI:229213

subject_name: Elacestrant

object_name: estrogen-receptor positive breast cancer


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Infection


subject: UNII:L500PR95QA

object_name: infectious disease


subject: UNII:L500PR95QA

object_name: Adverse Event Associated with Infection


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: CHEBI:6909


subject: UMLS:C0445115

subject_name: Normal saline


subject: UMLS:C0445115


subject: UMLS:C0445115


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: UMLS:C4042921

subject_name: Saline Waters

object_name: acne


subject: CHEBI:195559

subject_name: Poziotinib

object_name: Increased drug resistance


subject: UMLS:C3888350


subject: UNII:6897GXD6OE

object_name: osteoarthritis, hip


subject: UMLS:C1709400

object_name: glioblastoma


subject: UMLS:C1709400

object_name: Childhood Glioblastoma


subject: UMLS:C1709400

object_name: adult glioblastoma


subject: UMLS:C1709400

object_name: Recurrent Brain Neoplasm


subject: CHEBI:132268

subject_name: Dacomitinib


subject: CHEBI:132268


subject: CHEBI:132268


subject: CHEBI:132268


subject: PR:000017033

object_name: periodontal disorder


subject: UMLS:C0074512

subject_name: Signal Recognition Particle


subject: UMLS:C3640947

subject_name: HPV E6/E7 DNA Vaccine GX-188E

object_name: cervical intraepithelial neoplasia


subject: UMLS:C3640947

object_name: dysplasia of cervix


subject: CHEBI:231683

subject_name: Anakinra

object_name: Lower respiratory tract infection viral


subject: CHEBI:231683

object_name: Coronavinae infectious disease


subject: CHEBI:231683

object_name: viral disease


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: PR:000001137


subject: PR:000001137


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: diffuse large B-cell lymphoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: GTOPDB:8313

subject_name: talazoparib

object_name: leukemia


subject: GTOPDB:8313

object_name: childhood leukemia


subject: UMLS:C4305924

object_name: contact dermatitis


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Unresectable Fibrolamellar Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Hepatocellular Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Hepatocellular Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVA Hepatocellular Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IVB Hepatocellular Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIA Hepatocellular Carcinoma AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v8


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:H9CK7SS0T6

subject_name: recombinant interferon alpha 2b-like protein


subject: UNII:H9CK7SS0T6


subject: UNII:H9CK7SS0T6


subject: UNII:H9CK7SS0T6


subject: UNII:H9CK7SS0T6


subject: UNII:H9CK7SS0T6


subject: UNII:H9CK7SS0T6


subject: UMLS:C3273450

subject_name: Novaferon


subject: UMLS:C3273450


subject: UMLS:C3273450


subject: UMLS:C3273450


subject: UMLS:C3273450


subject: UMLS:C3273450


subject: UMLS:C3273450


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Inguinal hernia


subject: CHEBI:9448

subject_name: Terbinafine

object_name: tinea capitis


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:5801

object_name: obesity


subject: CHEBI:5801

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:3367

object_name: leukopenia


subject: PUBCHEM.COMPOUND:3367

object_name: neutropenia


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:4670

subject_name: Dobutamine

object_name: acute coronary syndrome


subject: CHEBI:4670

object_name: Low Cardiac Output Syndrome


subject: CHEBI:4670

object_name: pulmonary edema


subject: CHEBI:4670

object_name: Pulmonary Edema, CTCAE


subject: CHEBI:50693

subject_name: Milrinone


subject: CHEBI:50693

object_name: cardiogenic shock


subject: CHEBI:50693


subject: CHEBI:50693


subject: CHEBI:50693


subject: CHEBI:137064

subject_name: Galunisertib

object_name: rectum adenocarcinoma


subject: CHEBI:6427

subject_name: Leuprolide

object_name: infertility


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Sepsis


subject: PUBCHEM.COMPOUND:73151030

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:73151030

object_name: Inflammation


subject: PUBCHEM.COMPOUND:73151030

object_name: Organ dysfunction syndrome


subject: PUBCHEM.COMPOUND:73151030

object_name: Critical Illness


subject: CHEBI:132082

subject_name: Entinostat

object_name: Drug Interactions


subject: CHEBI:132082

object_name: Adverse drug interaction


subject: CHEBI:49956

subject_name: Xenon

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:49956

object_name: obesity


subject: CHEBI:49956

object_name: Obesity, CTCAE


subject: UMLS:C5432278

object_name: Childhood Solid Neoplasm


subject: UMLS:C5432278

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: intrahepatic bile duct cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: bile duct carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: bile duct cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: bile duct neoplasm


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879

object_name: colorectal neoplasm


subject: CHEBI:41879


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:193615


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C3712029

subject_name: tomaralimab

object_name: Myelodysplasia


subject: UMLS:C3712029

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C3712029

object_name: childhood myelodysplastic syndrome


subject: UMLS:C3712029

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C5555035

subject_name: A2A/A2B Adenosine Receptor Antagonist INCB106385

object_name: bladder tumor


subject: UMLS:C5555035

object_name: urinary bladder carcinoma


subject: UMLS:C5555035

object_name: urinary bladder cancer


subject: UMLS:C5555035

object_name: childhood bladder carcinoma


subject: UMLS:C5555035

object_name: ovarian cancer


subject: UMLS:C5555035

object_name: ovarian neoplasm


subject: UMLS:C5555035

object_name: ovarian carcinoma


subject: UMLS:C5555035

object_name: colorectal cancer


subject: UMLS:C5555035

object_name: colorectal carcinoma


subject: UMLS:C5555035

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5555035

object_name: triple-negative breast carcinoma


subject: UMLS:C5555035

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5555035

object_name: non-small cell lung carcinoma


subject: UMLS:C5555035

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5555035

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5555035

object_name: liver carcinoma


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: UMLS:C4688466


subject: CHEBI:81783

subject_name: Tricyclazole

object_name: mantle cell lymphoma


subject: UMLS:C4521565

subject_name: Beam -- chemical


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: achondroplasia


subject: UMLS:C5882209

object_name: type 2 diabetes mellitus


subject: UNII:MF497J489P

subject_name: MOSAPRIDE CITRATE

object_name: polyp of large intestine


subject: UMLS:C0245956

subject_name: Mosapride citrate


subject: CHEBI:167204

subject_name: Mosapride


subject: CHEBI:30742

subject_name: macrogol


subject: PR:000012224

subject_name: glycodelin


subject: UMLS:C5416840

subject_name: Platelet Lysate

object_name: Diabetic foot ulcer


subject: CHEBI:64064

subject_name: Salmeterol

object_name: Atopic rhinitis


subject: CHEBI:64064

object_name: Allergic Rhinitis, CTCAE


subject: UNII:3S182ET3UA

subject_name: TINZAPARIN SODIUM

object_name: cancer


subject: UNII:3S182ET3UA

object_name: neoplasm


subject: MESH:C578753

subject_name: faringel

object_name: Oral Mucositis


subject: MESH:C578753

object_name: stomatitis


subject: MESH:C578753

object_name: oral mucositis


subject: CHEBI:52010

subject_name: chlorphenamine

object_name: poisoning


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:93775

subject_name: Amethopterin

object_name: hydatidiform mole


subject: CHEBI:93775

object_name: hydatidiform mole, recurrent, 1


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: Musculoskeletal Pain


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:41039

subject_name: benfotiamine

object_name: diabetic kidney disease


subject: CHEBI:193615

object_name: Effects of chemotherapy


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:94463

object_name: hantavirus pulmonary syndrome


subject: CHEBI:63580

subject_name: Ribavirin


subject: UNII:41TIZ5663Z

object_name: multiple sclerosis


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: Childhood Solid Neoplasm


subject: UNII:Y6BX7BL23K

object_name: Adult Solid Neoplasm


subject: UNII:Y6BX7BL23K

object_name: FGFR Gene Translocation


subject: UNII:Y6BX7BL23K

object_name: FGFR Gene Rearrangement


subject: UNII:Y6BX7BL23K

object_name: FGFR Gene Mutation


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: rectal carcinoma


subject: CHEBI:39548

object_name: rectal cancer


subject: CHEBI:39548

object_name: Childhood Rectal Carcinoma


subject: CHEBI:39548

object_name: colon carcinoma


subject: CHEBI:39548

object_name: colorectal cancer


subject: CHEBI:39548

object_name: colon cancer


subject: CHEBI:39548

object_name: precancerous condition


subject: UMLS:C1831859

subject_name: Oligofructose-Enriched Inulin


subject: UMLS:C1831859


subject: UMLS:C1831859


subject: UMLS:C1831859


subject: UMLS:C1831859


subject: UMLS:C1831859


subject: UMLS:C1831859


subject: CHEBI:9352

subject_name: Sulindac


subject: CHEBI:9352


subject: CHEBI:9352


subject: CHEBI:9352


subject: CHEBI:9352


subject: CHEBI:9352


subject: CHEBI:41423

subject_name: Celecoxib

object_name: metastatic prostate carcinoma


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: liver neoplasm


subject: UMLS:C3896848

object_name: portal hypertension


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UNII:6A901E312A

object_name: gallbladder cancer


subject: UNII:6A901E312A

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UNII:6A901E312A

object_name: gallbladder carcinoma


subject: UNII:6A901E312A

object_name: biliary tract cancer


subject: UNII:6A901E312A

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:49956

subject_name: Xenon

object_name: developmental disorder; lungs


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Inguinal hernia


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UMLS:C2346819

subject_name: tanezumab

object_name: interstitial cystitis


subject: UMLS:C3896831

object_name: glioblastoma


subject: UMLS:C3896831

object_name: Childhood Glioblastoma


subject: UMLS:C3896831

object_name: adult glioblastoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: acute respiratory failure


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: pediatric angiosarcoma


subject: UNII:DPT0O3T46P

object_name: angiosarcoma


subject: UNII:DPT0O3T46P

object_name: Adult Angiosarcoma


subject: UNII:45KLN7N6UV

subject_name: VUSOLIMOGENE ODERPAREPVEC


subject: UNII:45KLN7N6UV


subject: UNII:45KLN7N6UV


subject: CHEBI:30044

subject_name: vanadium monoxide


subject: CHEBI:30044


subject: CHEBI:30044


subject: CHEBI:36791

subject_name: Escitalopram

object_name: psychosis


subject: CHEBI:3723

subject_name: Citalopram


subject: UMLS:C0762592

object_name: ovarian cancer


subject: UMLS:C0762592

object_name: ovarian neoplasm


subject: UMLS:C0762592

object_name: ovarian carcinoma


subject: UMLS:C0762592

object_name: fallopian tube neoplasm


subject: UMLS:C0762592

object_name: fallopian tube cancer


subject: UMLS:C0762592

object_name: peritoneal neoplasm


subject: UMLS:C0762592

object_name: peritoneum cancer


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:91083


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: systemic sclerosis


subject: CHEBI:71200

object_name: scleroderma


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: metastatic colorectal cancer


subject: UNII:DLE8519RWM

object_name: liver carcinoma


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: PUBCHEM.COMPOUND:57345941

subject_name: belizatinib

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:57345941

object_name: lymphoma


subject: UMLS:C3827071


subject: UMLS:C3827071


subject: MESH:C000615592

subject_name: Cereboost

object_name: Cognitive changes


subject: PUBCHEM.COMPOUND:162677492

subject_name: BALIXAFORTIDE

object_name: Carcinoma breast stage IV


subject: UNII:PRC974M49B


subject: UMLS:C4550002

subject_name: balixafortide


subject: PUBCHEM.COMPOUND:146599824

object_name: Acne inversa


subject: UNII:2SXR65P7E3


subject: CHEBI:17688

subject_name: Nicotine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:17688


subject: DRUGBANK:DB05361

object_name: coronary artery disorder


subject: DRUGBANK:DB05361

object_name: coronary atherosclerosis


subject: CHEBI:2922

subject_name: Auranofin

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:2922

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:9168

subject_name: Sirolimus


subject: UNII:4D28EY0L5T

subject_name: Dasotraline

object_name: binge eating


subject: PUBCHEM.COMPOUND:577181

subject_name: norsertraline


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: viral hepatitis


subject: CHEBI:59902

object_name: Viral Hepatitis, CTCAE


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:473990


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy


subject: PUBCHEM.COMPOUND:72370618


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: metastatic malignant neoplasm in the brain


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Pneumonia caused by SARS-CoV-2


subject: UMLS:C2827671

object_name: healthy, no evidence of disease


subject: UMLS:C5854547

subject_name: RIP1 Inhibitor GDC-8264

object_name: acute graft versus host disease


subject: PUBCHEM.COMPOUND:16138701

subject_name: DiaPep 277

object_name: Diabetes, Autoimmune


subject: UNII:F8778UWB0A


subject: CHEBI:35111

subject_name: calcium monohydroxide

object_name: dental pulp necrosis


subject: CHEBI:35150

subject_name: calcium hydroxide


subject: CHEBI:31341

subject_name: calcium dihydroxide


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: MESH:C086631

subject_name: mineral trioxide aggregate


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:17509


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: AIDS


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: UNII:S7V92P67HO


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: autoimmune hepatitis


subject: UMLS:C0378942


subject: UMLS:C0392938

subject_name: zoledronate

object_name: triple-negative breast carcinoma


subject: UMLS:C0392938

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: UMLS:C5787183

subject_name: MEK Inhibitor REC-4881

object_name: Childhood Solid Neoplasm


subject: UMLS:C5787183

object_name: Adult Solid Neoplasm


subject: UMLS:C5787183

object_name: Solid Neoplasm


subject: UMLS:C5787183

object_name: APC Gene Mutation


subject: UMLS:C5787183

object_name: AXIN1 Gene Mutation


subject: UMLS:C1699394

subject_name: Hylenex

object_name: HIV infection


subject: CHEBI:229764

subject_name: Selinexor

object_name: glioblastoma


subject: CHEBI:229764

object_name: Brain Stem Glioblastoma


subject: CHEBI:229764

object_name: glioma susceptibility 1


subject: UMLS:C5448053

object_name: non-small cell lung carcinoma


subject: CHEBI:16335

subject_name: Adenosine

object_name: liver neoplasm


subject: CHEBI:63660

object_name: preeclampsia


subject: CHEBI:63660

object_name: hypertension, pregnancy-induced


subject: CHEBI:63660

object_name: Maternal hypertension


subject: CHEBI:63660

object_name: Obstetric Labor Complications


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:63618


subject: CHEBI:62097

object_name: neoplasm of esophagus


subject: CHEBI:33367

subject_name: darmstadtium


subject: CHEBI:34699

subject_name: diethyl sulfate


subject: CHEBI:73454

subject_name: Asp-Ser


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:66910

subject_name: Axitinib

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:134989

subject_name: Taribavirin

object_name: hepatitis C


subject: CHEBI:134989

object_name: chronic hepatitis C virus infection


subject: UMLS:C5959679

subject_name: Anti-TNFR2 Monoclonal Antibody BI-1910

object_name: Solid Neoplasm


subject: UMLS:C5959679


subject: UMLS:C5959679

object_name: liver carcinoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:73604

object_name: Fatigue


subject: CHEBI:73604

object_name: pancreatic neoplasm


subject: CHEBI:73604

object_name: exocrine pancreatic carcinoma


subject: CHEBI:73604

object_name: malignant pancreatic neoplasm


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: CHEBI:63724

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:74947

subject_name: Thalidomide


subject: PUBCHEM.COMPOUND:57654476

object_name: neoplasm


subject: UMLS:C4725111

subject_name: MET Kinase Inhibitor OMO-1


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Laryngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVC squamous cell carcinoma of the larynx


subject: PUBCHEM.COMPOUND:131769963

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVA squamous cell carcinoma of the larynx


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVB squamous cell carcinoma of the larynx


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: salivary gland squamous cell carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: PUBCHEM.COMPOUND:131769963

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: PUBCHEM.COMPOUND:131769963

object_name: untreated metastatic squamous neck cancer with occult primary


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: PUBCHEM.COMPOUND:131769963

object_name: Laryngeal verrucous carcinoma recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVC verrucous carcinoma of the larynx


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVB verrucous carcinoma of the larynx


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVA verrucous carcinoma of the larynx


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: tongue cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: tongue carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Recurrent Salivary Gland Cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVC salivary gland cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVA salivary gland cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: stage IVB salivary gland cancer


subject: UNII:5XYK65KIGD

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:5XYK65KIGD

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:5XYK65KIGD

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:5XYK65KIGD

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: UNII:5XYK65KIGD

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: UNII:5XYK65KIGD

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:5XYK65KIGD

object_name: stage IVC squamous cell carcinoma of the larynx


subject: UNII:5XYK65KIGD

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UNII:5XYK65KIGD

object_name: stage IVA squamous cell carcinoma of the larynx


subject: UNII:5XYK65KIGD

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:5XYK65KIGD

object_name: stage IVB squamous cell carcinoma of the larynx


subject: UNII:5XYK65KIGD

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:5XYK65KIGD

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: UNII:5XYK65KIGD

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: UNII:5XYK65KIGD

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:5XYK65KIGD

object_name: salivary gland squamous cell carcinoma


subject: UNII:5XYK65KIGD

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:5XYK65KIGD

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: UNII:5XYK65KIGD

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:5XYK65KIGD

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: UNII:5XYK65KIGD

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:5XYK65KIGD

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: UNII:5XYK65KIGD

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: UNII:5XYK65KIGD

object_name: untreated metastatic squamous neck cancer with occult primary


subject: UNII:5XYK65KIGD

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: UNII:5XYK65KIGD

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: UNII:5XYK65KIGD

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: UNII:5XYK65KIGD

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UNII:5XYK65KIGD

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:5XYK65KIGD

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:5XYK65KIGD

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: UNII:5XYK65KIGD

object_name: Laryngeal verrucous carcinoma recurrent


subject: UNII:5XYK65KIGD

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: UNII:5XYK65KIGD

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:5XYK65KIGD

object_name: stage IVC verrucous carcinoma of the larynx


subject: UNII:5XYK65KIGD

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:5XYK65KIGD

object_name: stage IVB verrucous carcinoma of the larynx


subject: UNII:5XYK65KIGD

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: UNII:5XYK65KIGD

object_name: stage IVA verrucous carcinoma of the larynx


subject: UNII:5XYK65KIGD

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: UNII:5XYK65KIGD

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: UNII:5XYK65KIGD

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: UNII:5XYK65KIGD

object_name: tongue cancer


subject: UNII:5XYK65KIGD

object_name: tongue carcinoma


subject: UNII:5XYK65KIGD

object_name: Recurrent Salivary Gland Cancer


subject: UNII:5XYK65KIGD

object_name: stage IVC salivary gland cancer


subject: UNII:5XYK65KIGD

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: UNII:5XYK65KIGD

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: UNII:5XYK65KIGD

object_name: stage IVA salivary gland cancer


subject: UNII:5XYK65KIGD

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: UNII:5XYK65KIGD

object_name: stage IVB salivary gland cancer


subject: CHEBI:50924

subject_name: Sorafenib

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:50924

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:50924

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:50924

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:50924

object_name: recurrent metastatic squamous neck cancer with occult primary


subject: CHEBI:50924

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:50924

object_name: stage IVC squamous cell carcinoma of the larynx


subject: CHEBI:50924

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:50924

object_name: stage IVA squamous cell carcinoma of the larynx


subject: CHEBI:50924

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:50924

object_name: stage IVB squamous cell carcinoma of the larynx


subject: CHEBI:50924

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:50924

object_name: Recurrent Lip and Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:50924

object_name: stage IVC squamous cell carcinoma of the oropharynx


subject: CHEBI:50924

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:50924

object_name: salivary gland squamous cell carcinoma


subject: CHEBI:50924

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:50924

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:50924

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:50924

object_name: stage IVB squamous cell carcinoma of the oropharynx


subject: CHEBI:50924

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:50924

object_name: stage IVA squamous cell carcinoma of the oropharynx


subject: CHEBI:50924

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:50924

object_name: untreated metastatic squamous neck cancer with occult primary


subject: CHEBI:50924

object_name: stage IVC squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:50924

object_name: stage IVA squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:50924

object_name: stage IVB squamous cell carcinoma of the lip and oral cavity


subject: CHEBI:50924

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: CHEBI:50924

object_name: stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:50924

object_name: stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:50924

object_name: stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:50924

object_name: Laryngeal verrucous carcinoma recurrent


subject: CHEBI:50924

object_name: Verrucous carcinoma of the oral cavity recurrent


subject: CHEBI:50924

object_name: Stage IVC Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:50924

object_name: stage IVC verrucous carcinoma of the larynx


subject: CHEBI:50924

object_name: Stage IVB Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:50924

object_name: stage IVB verrucous carcinoma of the larynx


subject: CHEBI:50924

object_name: Stage IVA Laryngeal Verrucous Carcinoma AJCC v7


subject: CHEBI:50924

object_name: stage IVA verrucous carcinoma of the larynx


subject: CHEBI:50924

object_name: Stage IVA Oral Cavity Verrucous Carcinoma


subject: CHEBI:50924

object_name: Stage IVB Oral Cavity Verrucous Carcinoma


subject: CHEBI:50924

object_name: Stage IVC Oral Cavity Verrucous Carcinoma


subject: CHEBI:50924

object_name: tongue cancer


subject: CHEBI:50924

object_name: tongue carcinoma


subject: CHEBI:50924

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:50924

object_name: stage IVC salivary gland cancer


subject: CHEBI:50924

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:50924

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:50924

object_name: stage IVA salivary gland cancer


subject: CHEBI:50924

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:50924

object_name: stage IVB salivary gland cancer


subject: UNII:6NV440YIO0

subject_name: Simufilam

object_name: Alzheimer disease


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: sarcoma


subject: GTOPDB:9592

object_name: soft tissue sarcoma


subject: GTOPDB:9592

object_name: pediatric angiosarcoma


subject: GTOPDB:9592

object_name: angiosarcoma


subject: GTOPDB:9592

object_name: Adult Angiosarcoma


subject: GTOPDB:9592

object_name: fibrosarcoma


subject: GTOPDB:9592

object_name: adult fibrosarcoma


subject: GTOPDB:9592

object_name: pediatric fibrosarcoma


subject: GTOPDB:9592

object_name: leiomyosarcoma


subject: GTOPDB:9592

object_name: Childhood Leiomyosarcoma


subject: GTOPDB:9592

object_name: Adult Leiomyosarcoma


subject: GTOPDB:9592

object_name: pleomorphic liposarcoma


subject: GTOPDB:9592

object_name: malignant peripheral nerve sheath tumor


subject: GTOPDB:9592

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: GTOPDB:9592

object_name: desmoplastic small round cell tumor


subject: GTOPDB:9592

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: UMLS:C1675748

object_name: melanoma


subject: UMLS:C1675748

object_name: breast neoplasm


subject: UMLS:C1675748

object_name: Colon Neoplasm


subject: CHEBI:88249

subject_name: Mirdametinib


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Bilateral primary open angle glaucoma


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:18140

object_name: castration-resistant prostate carcinoma


subject: CHEBI:4868

subject_name: Estramustine


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: UNII:3JGY52XJNA

subject_name: Lutropin alfa

object_name: infertility


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: blepharospasm


subject: DRUGBANK:DB05899

object_name: ovarian cancer


subject: DRUGBANK:DB05899

object_name: ovarian neoplasm


subject: DRUGBANK:DB05899

object_name: ovarian carcinoma


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Cortisol deficiency


subject: CHEBI:167574

object_name: adrenocortical insufficiency


subject: CHEBI:167574

object_name: Adrenal Insufficiency, CTCAE


subject: CHEBI:31785

subject_name: loxiglumide

object_name: irritable bowel syndrome


subject: CHEBI:135747

subject_name: Dexloxiglumide


subject: UMLS:C4330473

subject_name: Idronoxil Suppository NOX66


subject: DRUGBANK:DB17559

object_name: acute myeloid leukemia by FAB classification


subject: DRUGBANK:DB17559

object_name: acute myeloid leukemia


subject: CHEBI:113532

subject_name: Thymoquinone

object_name: Androgen excess


subject: CHEBI:74855

subject_name: Thr-Gln


subject: UNII:ZO763K43XR

subject_name: TOCOQUINONE


subject: PUBCHEM.COMPOUND:121268274

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:121268274

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: UNII:8M7YSN2KII


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: fibromyalgia


subject: CHEBI:178199

subject_name: Sotorasib

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:8230

subject_name: Argipressin

object_name: Acute Pain


subject: UMLS:C1527128

subject_name: Recombinant Vasopressin


subject: UMLS:C0003779

subject_name: argipressin


subject: PUBCHEM.COMPOUND:53477739

subject_name: Vasopressin


subject: CHEBI:28892

subject_name: ganglioside

object_name: inflammatory bowel disease


subject: UNII:ZDR4QSJ43F

object_name: Cervical Squamous Cell Carcinoma In Situ


subject: UNII:ZDR4QSJ43F

object_name: Vulval intraepithelial neoplasia grade 2


subject: UMLS:C0758290

subject_name: IRX 2


subject: UMLS:C0758290


subject: UMLS:C1541530

object_name: neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Neck Squamous Cell Carcinoma of Unknown Primary


subject: UNII:DPT0O3T46P

object_name: Recurrent Sinonasal Squamous Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:DPT0O3T46P

object_name: Stage IVB Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IVC Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage III Nasopharyngeal Carcinoma AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage III Nasopharyngeal Carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage IV Nasopharyngeal Carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v7


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:45716

object_name: head and neck squamous cell carcinoma


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716

object_name: Nasopharyngeal cancer recurrent


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: CNS disorder


subject: UMLS:C3154257

subject_name: Gadavist


subject: UMLS:C0388020

subject_name: Gadovist


subject: UMLS:C2713023


subject: HMDB:HMDB0014735

subject_name: Gadoteridol


subject: CHEBI:31643


subject: UMLS:C0245925

subject_name: Prohance


subject: UMLS:C4744807

subject_name: Anti-CD46 Antibody-drug Conjugate FOR46

object_name: metastatic prostate carcinoma


subject: CHEBI:39112

subject_name: Bosutinib

object_name: Blast Phase


subject: CHEBI:39112

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: acute kidney failure


subject: CHEBI:39548

object_name: Acute Kidney Injury, CTCAE


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: Parkinson disease


subject: HMDB:HMDB0013470

object_name: neurodegenerative disease


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: CHEBI:16412


subject: PUBCHEM.COMPOUND:155977629


subject: PUBCHEM.COMPOUND:155977629


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:89981


subject: CHEBI:49631

subject_name: gallium atom

object_name: central nervous system cancer


subject: CHEBI:49631

object_name: brain neoplasm


subject: UMLS:C1617822

subject_name: Indium in-111 pentetate, diagnostic, per 0.5 millicurie


subject: UMLS:C1617822


subject: CHEBI:135905

subject_name: Terlipressin

object_name: Complication of transplanted liver


subject: CHEBI:90942

subject_name: Ixazomib

object_name: mantle cell lymphoma


subject: CHEBI:84507

subject_name: Chantix

object_name: Nicotine Addiction


subject: CHEBI:84507

object_name: Craving


subject: PUBCHEM.COMPOUND:53486179

subject_name: VARENICLINE TARTRATE

object_name: nicotine dependence


subject: PUBCHEM.COMPOUND:53486179


subject: PUBCHEM.COMPOUND:53486179


subject: CHEBI:84500

subject_name: varenicline


subject: CHEBI:84500


subject: CHEBI:8382

subject_name: Prednisone

object_name: pervasive developmental disorder


subject: CHEBI:8382

object_name: autism


subject: CHEBI:8382

object_name: autism spectrum disorder


subject: UNII:40497CY7Y3

object_name: chronic pain (diagnosis)


subject: UNII:40497CY7Y3

object_name: Chronic pain


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Resectable non-small cell lung cancer


subject: UNII:6QVL057INT

subject_name: Cemiplimab


subject: UMLS:C4053601


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB


subject: UMLS:C4329332

subject_name: Fianlimab


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:46191477

object_name: retinitis pigmentosa


subject: PUBCHEM.COMPOUND:46191477

object_name: retinitis pigmentosa 1


subject: PUBCHEM.COMPOUND:46191477

object_name: choroideremia


subject: UNII:57HBP7XKS9


subject: UNII:57HBP7XKS9


subject: UNII:57HBP7XKS9


subject: CHEBI:91985

subject_name: nadolol

object_name: hypertension


subject: CHEBI:91985

object_name: migraine


subject: CHEBI:91985

object_name: Chest pain


subject: PUBCHEM.COMPOUND:14794883

subject_name: Folerogenin


subject: PUBCHEM.COMPOUND:14794883


subject: PUBCHEM.COMPOUND:14794883


subject: MESH:D013607

subject_name: Tablets


subject: MESH:D013607


subject: MESH:D013607


subject: UNII:Q830PW7520

subject_name: CODEINE

object_name: Musculoskeletal Pain


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:57871


subject: CHEBI:16714

subject_name: Codeine


subject: CHEBI:5779

subject_name: Hydrocodone


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: gastric adenocarcinoma


subject: CHEBI:72317

object_name: gastroesophageal cancer


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Multiple myeloma and malignant plasma cell neoplasms


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: UMLS:C0733688

object_name: myeloproliferative neoplasm


subject: UMLS:C0733688

object_name: Myelodysplasia


subject: UMLS:C0733688

object_name: leukemia


subject: UMLS:C0733688

object_name: childhood leukemia


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: hyperlipoproteinemia type 3


subject: UMLS:C1135119

subject_name: Iseganan HCl Oral Solution

object_name: Neck Carcinoma


subject: UMLS:C1135119

object_name: head and neck neoplasm


subject: UMLS:C1135119

object_name: head and neck cancer


subject: UMLS:C1135119

object_name: Radiation Sickness


subject: UMLS:C1135119

object_name: Oral Complication of Radiation Therapy


subject: UMLS:C5240156

subject_name: Vaccine product containing only Streptococcus pneumoniae capsular polysaccharide antigen conjugated (medicinal product)

object_name: meningococcal meningitis


subject: UMLS:C5240156

object_name: meningococcal infection


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Metastatic malignant neoplasm to pancreas


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Critical Illness


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:18248

subject_name: Iron


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: Heartburn


subject: CHEBI:15377

subject_name: Water


subject: PR:000002327

subject_name: gelsolin isoform 1

object_name: septic shock


subject: UMLS:C4722590

object_name: acne


subject: MESH:C078788

subject_name: ALVAC vaccine

object_name: melanoma


subject: MESH:C078788

object_name: cancer


subject: MESH:C078788

object_name: neoplasm


subject: UMLS:C2981806


subject: UMLS:C2981806


subject: UNII:A9C8MNF7CA

subject_name: Prinaberel

object_name: interstitial cystitis


subject: CHEBI:4445

subject_name: Desflurane

object_name: pituitary gland adenoma


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:9130

subject_name: Sevoflurane


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Rash and Dermatitis Associated with Chemoradiation, CTCAE


subject: CHEBI:133017

subject_name: Pimavanserin

object_name: endogenous depression


subject: CHEBI:133017

object_name: major depressive disorder


subject: CHEBI:172923

subject_name: FLUORESCEIN

object_name: endometrial cancer


subject: CHEBI:172923

object_name: uterine corpus cancer


subject: CHEBI:172923

object_name: endometrial carcinoma


subject: CHEBI:2611

subject_name: Alprazolam

object_name: epilepsy


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: type C thymoma


subject: UNII:D99YVK4L0X

object_name: thymoma


subject: UNII:D99YVK4L0X

object_name: thymus neoplasm


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: CHEBI:9112

subject_name: sennoside A

object_name: intestinal obstruction


subject: CHEBI:9112

object_name: inflammatory bowel disease


subject: CHEBI:9112

object_name: perinatal necrotizing enterocolitis


subject: CHEBI:9112

object_name: necrotizing enterocolitis


subject: CHEBI:9112

object_name: Necrotizing Enterocolitis, AE


subject: CHEBI:9112

object_name: Colostomy site


subject: CHEBI:9112

object_name: Colostomy stoma


subject: CHEBI:9112

object_name: Has colostomy


subject: CHEBI:9112

object_name: meconium ileus


subject: CHEBI:9112

object_name: intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency


subject: DRUGBANK:DB15889

subject_name: Senna leaf


subject: DRUGBANK:DB15889


subject: DRUGBANK:DB15889


subject: DRUGBANK:DB15889


subject: DRUGBANK:DB15889


subject: DRUGBANK:DB15889


subject: DRUGBANK:DB15889


subject: DRUGBANK:DB15889


subject: DRUGBANK:DB15889


subject: DRUGBANK:DB15889


subject: CHEMBL.COMPOUND:CHEMBL2108558

subject_name: SENNA


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: CHEMBL.COMPOUND:CHEMBL2108558


subject: UNII:3FYP5M0IJX

subject_name: Sennosides


subject: UNII:3FYP5M0IJX


subject: UNII:3FYP5M0IJX


subject: UNII:3FYP5M0IJX


subject: UNII:3FYP5M0IJX


subject: UNII:3FYP5M0IJX


subject: UNII:3FYP5M0IJX


subject: UNII:3FYP5M0IJX


subject: UNII:3FYP5M0IJX


subject: UNII:3FYP5M0IJX


subject: UNII:95D580798S

subject_name: Picosulfuric acid


subject: UNII:95D580798S


subject: UNII:95D580798S


subject: UNII:95D580798S


subject: UNII:95D580798S


subject: UNII:95D580798S


subject: UNII:95D580798S


subject: UNII:95D580798S


subject: UNII:95D580798S


subject: UNII:3A3U0GI71G

subject_name: Magnesium oxide


subject: UNII:3A3U0GI71G


subject: UNII:3A3U0GI71G


subject: UNII:3A3U0GI71G


subject: UNII:3A3U0GI71G


subject: UNII:3A3U0GI71G


subject: UNII:3A3U0GI71G


subject: UNII:3A3U0GI71G


subject: UNII:3A3U0GI71G


subject: UNII:3A3U0GI71G


subject: CHEBI:31794

subject_name: magnesium oxide


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:31794


subject: CHEBI:30769

subject_name: Citric acid


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:30769


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: liver failure


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: CHEBI:33380

subject_name: thulium atom

object_name: prostate carcinoma


subject: CHEBI:33380

object_name: prostate cancer


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: CHEBI:6456

subject_name: Lidocaine

object_name: IUD insertion complication


subject: CHEBI:6456

object_name: Demonstrates adequate pain control


subject: CHEBI:135552

subject_name: Prucalopride

object_name: schizophrenia


subject: UMLS:C1134696

object_name: Neoplasm Metastasis


subject: UMLS:C1134696

object_name: neoplasm


subject: CHEBI:167997

subject_name: Cellulose, microcrystalline

object_name: Chronic low back pain


subject: CHEBI:62968

subject_name: Microcrystalline cellulose


subject: CHEBI:49603

subject_name: Lapatinib

object_name: head and neck squamous cell carcinoma


subject: UMLS:C1611967

object_name: atrial fibrillation


subject: UMLS:C1611967

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C1611967

object_name: Atrial Fibrillation, CTCAE


subject: MESH:C000718667

subject_name: mastiha

object_name: inflammatory bowel disease


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Menopause present (finding)


subject: UMLS:C0013227

object_name: Menopause


subject: UMLS:C0013227

object_name: Bone Demineralization, Pathologic


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C5402536

subject_name: Breztri Aerosphere

object_name: Cough


subject: UMLS:C5402536

object_name: Cough, CTCAE


subject: UMLS:C5402536

object_name: non-small cell lung carcinoma


subject: UMLS:C5402536

object_name: Drug action (disorder)


subject: UMLS:C5402536

object_name: Drug toxicity


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Advanced Clear Cell Renal Cell Carcinoma


subject: CHEBI:231614

object_name: Clear-cell metastatic renal cell carcinoma


subject: CHEBI:231614

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib


subject: UNII:CWG62Q1VTB


subject: UNII:CWG62Q1VTB


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Metastatic Colorectal Adenocarcinoma


subject: UMLS:C3827082


subject: UNII:BTY153760O

subject_name: Ixekizumab

object_name: pyoderma gangrenosum


subject: UNII:NU90V55F8I

subject_name: Sarilumab

object_name: temporal arteritis


subject: UNII:NU90V55F8I

object_name: polymyalgia rheumatica


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: severe acute respiratory syndrome


subject: CHEBI:31355

subject_name: Carboplatin

object_name: paranasal sinus neoplasm


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:4672

subject_name: Docetaxel


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989

object_name: sinonasal undifferentiated carcinoma


subject: GTOPDB:12989

object_name: squamous cell carcinoma


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C0392938

subject_name: zoledronate

object_name: cervical cancer


subject: UMLS:C0392938

object_name: cervical carcinoma


subject: UMLS:C0392938

object_name: precancerous condition


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: UMLS:C4510275

subject_name: Sulfur hexafluoride lipid microsphere

object_name: Cirrhosis


subject: UMLS:C4510275

object_name: liver cirrhosis


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:72690

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:72690

object_name: sarcoma


subject: CHEBI:72690

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:72690

object_name: soft tissue sarcoma


subject: UNII:41J7ZJ239R

object_name: small cell lung carcinoma


subject: UMLS:C3254127

subject_name: polyethylene glycol-recombinant human growth hormone

object_name: growth hormone treatment


subject: UMLS:C3254127

object_name: Developmental disorders cognitive


subject: UMLS:C3254127

object_name: fetal growth restriction


subject: CHEBI:4670

subject_name: Dobutamine

object_name: cardio-renal syndrome


subject: UNII:349552KRHK

subject_name: Simendan


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Insulin resistance


subject: CHEBI:124959

subject_name: Tilarginine

object_name: type 2 diabetes mellitus


subject: CHEBI:124959


subject: CHEBI:124959

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:124959

object_name: obesity


subject: CHEBI:124959

object_name: Obesity, CTCAE


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: UMLS:C0069477


subject: CHEBI:16664

subject_name: Albendazole

object_name: malnutrition


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine


subject: UMLS:C5787183

subject_name: MEK Inhibitor REC-4881

object_name: classic familial adenomatous polyposis


subject: UMLS:C5787183

object_name: Adenomatous colonic polyposis


subject: PUBCHEM.COMPOUND:131750188

subject_name: sterofundin

object_name: Postoperative Complications


subject: UMLS:C3495434

subject_name: hydroxyethyl starch 130-0.4


subject: CHEBI:74947

subject_name: Thalidomide

object_name: sarcoidosis


subject: CHEBI:74947

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: premature ejaculation


subject: UMLS:C4727634

subject_name: CT-053 Tosylate

object_name: adult acute myeloid leukemia


subject: UMLS:C4727634

object_name: childhood acute myeloid leukemia


subject: UMLS:C4727634

object_name: acute myeloid leukemia


subject: CHEBI:18145

subject_name: Vitamin E

object_name: male infertility


subject: DRUGBANK:DB10429

subject_name: Yeast


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: gastric neoplasm


subject: CHEBI:94518

object_name: stomach polyp


subject: CHEBI:94518

object_name: duodenum cancer


subject: CHEBI:94518

object_name: tumor of duodenum


subject: CHEBI:94518

object_name: neoplasm of esophagus


subject: UMLS:C0909027

subject_name: dai-kenchu-to

object_name: Functional constipation


subject: UNII:N3KQ8A1E0X


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: childhood acute lymphoblastic leukemia


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma


subject: GTOPDB:11376

object_name: Stage IV Lung Cancer AJCC v8


subject: GTOPDB:11376

object_name: Stage III Lung Cancer AJCC v8


subject: GTOPDB:11376

object_name: Stage IVA Lung Cancer AJCC v8


subject: GTOPDB:11376

object_name: Stage IVB Lung Cancer AJCC v8


subject: GTOPDB:11376

object_name: Stage IIIC Lung Cancer AJCC v8


subject: GTOPDB:11376

object_name: Stage IIIA Lung Cancer AJCC v8


subject: GTOPDB:11376

object_name: Stage IIIB Lung Cancer AJCC v8


subject: GTOPDB:11376

object_name: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma


subject: GTOPDB:11376

object_name: Unresectable Lung Non-Squamous Non-Small Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:8378

subject_name: Prednisolone

object_name: cancer


subject: CHEBI:8378

object_name: neoplasm


subject: CHEBI:8378

object_name: Malignant ascites


subject: CHEBI:8378

object_name: carcinoma


subject: CHEBI:166520

subject_name: Tenamfetamine

object_name: Encounter due to psychotherapy


subject: CHEBI:1391

subject_name: Midomafetamine


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: acute coronary syndrome


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:53394

subject_name: phosphotungstic acid macromolecule

object_name: diabetic foot


subject: CHEBI:61432

subject_name: phosphotungstic acid polymer


subject: UMLS:C5556424

subject_name: Lumrotatug

object_name: Alloimmune platelet transfusion refractoriness


subject: CHEBI:33330

subject_name: scandium atom


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: cystic fibrosis


subject: CHEBI:2666

object_name: pneumonia


subject: CHEBI:2666

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:3175

subject_name: Brimonidine

object_name: drugs; glaucoma


subject: CHEBI:3175

object_name: ptosis


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Uterine Pain


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: dilated cardiomyopathy 3B


subject: CHEBI:231679

subject_name: ipilimumab

object_name: lung adenocarcinoma


subject: CHEBI:231679

object_name: adenocarcinoma


subject: CHEBI:231679

object_name: bile duct adenocarcinoma


subject: CHEBI:7459

subject_name: Naloxone

object_name: Opiate Overdose


subject: UMLS:C3490349

object_name: type 1 diabetes mellitus 1


subject: UMLS:C3490349

object_name: type 1 diabetes mellitus


subject: UMLS:C5203268

subject_name: Pegaptanib Sodium Injection

object_name: age-related macular degeneration


subject: UMLS:C5203268

object_name: diabetic macular edema


subject: UMLS:C5203268

object_name: retinal vein occlusion


subject: UMLS:C1621008

subject_name: INJECTION, PEGAPTANIB SODIUM, 0.3 MG Administered


subject: UMLS:C1621008


subject: UMLS:C1621008


subject: UMLS:C4733478

subject_name: Chinese herbal formulation ChangTai Keli

object_name: colon carcinoma


subject: UMLS:C4733478

object_name: colorectal cancer


subject: UMLS:C4733478

object_name: colon cancer


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox


subject: PUBCHEM.COMPOUND:71301229


subject: CHEBI:7773

subject_name: Ondansetron

object_name: cocaine dependence


subject: CHEBI:6456

subject_name: Lidocaine


subject: UMLS:C4329334

subject_name: Ezabenlimab

object_name: anal canal squamous cell carcinoma


subject: UMLS:C4287781


subject: CHEBI:8707

subject_name: Quetiapine

object_name: Agitation


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: osteoarthritis, knee


subject: CHEBI:681569

subject_name: Clofarabine

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:3613823

object_name: exocrine pancreatic insufficiency


subject: PUBCHEM.COMPOUND:3613823

object_name: cystic fibrosis


subject: CHEMBL.COMPOUND:CHEMBL4298049


subject: CHEMBL.COMPOUND:CHEMBL4298049


subject: UMLS:C5139803


subject: UMLS:C5139803


subject: CHEBI:8774

subject_name: Ramipril

object_name: proteinuria


subject: CHEBI:8774

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:8774

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:8774

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:8774

object_name: chronic kidney disease


subject: CHEBI:8774

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: Childhood Breast Carcinoma


subject: UNII:Y6BX7BL23K

object_name: breast carcinoma


subject: UNII:Y6BX7BL23K

object_name: breast cancer


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR

object_name: Cardiac amyloidosis


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Abdominal wall defect


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Mycosis fungoides/Sezary syndrome


subject: UNII:52CMI0WC3Y

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UNII:52CMI0WC3Y

object_name: primary cutaneous T-cell lymphoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: melanoma


subject: UMLS:C0962969

subject_name: RAD 001

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C0962969

object_name: Metastatic Renal Cell Cancer


subject: PUBCHEM.COMPOUND:9805430

subject_name: Apadenoson

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:9805430

object_name: coronary atherosclerosis


subject: UNII:BTS1Y6777M


subject: UNII:BTS1Y6777M


subject: UMLS:C0042210

subject_name: Vaccines

object_name: HIV-1 infection


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:31355

subject_name: Carboplatin

object_name: gastroesophageal cancer


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: carcinoma of esophagus


subject: UNII:AF75XOF6W3

object_name: esophageal cancer


subject: UNII:AF75XOF6W3

object_name: Childhood Esophageal Carcinoma


subject: UNII:AF75XOF6W3

object_name: neoplasm of esophagus


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3

object_name: Stomach cancer


subject: UNII:AF75XOF6W3

object_name: gastric cancer


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: CHEBI:27504

subject_name: Mitomycin

object_name: OPTN-related open angle glaucoma


subject: CHEBI:27504

object_name: open-angle glaucoma


subject: CHEBI:188074

object_name: Insulin Sensitivity


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:41423

subject_name: Celecoxib

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:50169

subject_name: Brexanolone

object_name: postpartum psychosis


subject: UMLS:C3854325

subject_name: Janus kinase inhibitor

object_name: Pemphigoid


subject: UMLS:C3854326

subject_name: Janus Kinase Inhibitor [EPC]


subject: UMLS:C0305065

subject_name: Polyvalent pneumococcal vaccine

object_name: age


subject: UMLS:C4722726

object_name: Solid Neoplasm


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: coronary microvascular disorder


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: colorectal neoplasm


subject: UMLS:C0733521

subject_name: Ara-C

object_name: acute lymphoblastic leukemia


subject: CHEBI:45652

subject_name: Succinylcholine

object_name: Neuromuscular inhibition


subject: CHEBI:45652

object_name: Neuromuscular block, function


subject: CHEBI:26710

subject_name: Sodium chloride